Invion Ltd. (AU:IVX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Invion Limited has announced the appointment of Mr. Tai Phan as the new Company Secretary, bringing his extensive 20-year experience in legal, corporate governance, and compliance roles across various industries to the role. This change comes as Ms. Claire Newstead-Sinclair steps down from the position, with the company expressing gratitude for her service. Invion specializes in the development of Photosoft™ technology for treating cancers, atherosclerosis, and infectious diseases, and is involved in clinical cancer trials funded by RMW Cho Group Limited.
For further insights into AU:IVX stock, check out TipRanks’ Stock Analysis page.